HAL (France)open access
Clinical impact of extrahepatic metastatic patterns in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab
CIs, BCLC, ESMO, Interquartile range, OS, Overall survival, Complete response, TKI
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 274199
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.